A H Talal - JoVE Visualize

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Postgraduate Medicine|September 1, 1994

Acute and chronic diarrhea. How to keep laboratory testing to a minimumA H Talal, J A Murray

Gastroenterology Clinics of North America|September 1, 1995

Psychosocial factors in inflammatory bowel diseaseA H Talal, D A Drossman

Journal of Viral Hepatitis|September 19, 2007

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infectionM Zeremski, L M Petrovic, A H Talal

Gastroenterology Clinics of North America|June 1, 1997

Molecular diagnosis of gastrointestinal infections associated with HIV infectionA H Talal, L M Weiss, C Vanderhorst

The American Journal of Gastroenterology|August 1, 1997

Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testingA H Talal, J A Murray, J A Goeken, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998

Detection of Enterocytozoon bieneusi in fecal specimens by polymerase chain reaction analysis with primers to the small-subunit rRNAA H Talal, D P Kotler, J M Orenstein, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001

Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissueA H Talal, C E Irwin, D T Dieterich, et al.

Journal of Viral Hepatitis|July 6, 2012

Hepatitis C virus-specific immune responses in noninjecting drug usersM Zeremski, J Makeyeva, K Arasteh, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003

Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infectionD M DiMichele, G Mirani, P Wilfredo Canchis, et al.

Alimentary Pharmacology & Therapeutics|January 8, 2013

Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patientsA H Talal, J LaFleur, R Hoop, et al.

Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Postgraduate Medicine|September 1, 1994

Acute and chronic diarrhea. How to keep laboratory testing to a minimumA H Talal, J A Murray

Gastroenterology Clinics of North America|September 1, 1995

Psychosocial factors in inflammatory bowel diseaseA H Talal, D A Drossman

Journal of Viral Hepatitis|September 19, 2007

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infectionM Zeremski, L M Petrovic, A H Talal

Gastroenterology Clinics of North America|June 1, 1997

Molecular diagnosis of gastrointestinal infections associated with HIV infectionA H Talal, L M Weiss, C Vanderhorst

The American Journal of Gastroenterology|August 1, 1997

Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testingA H Talal, J A Murray, J A Goeken, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998

Detection of Enterocytozoon bieneusi in fecal specimens by polymerase chain reaction analysis with primers to the small-subunit rRNAA H Talal, D P Kotler, J M Orenstein, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001

Effect of HIV-1 infection on lymphocyte proliferation in gut-associated lymphoid tissueA H Talal, C E Irwin, D T Dieterich, et al.

Journal of Viral Hepatitis|July 6, 2012

Hepatitis C virus-specific immune responses in noninjecting drug usersM Zeremski, J Makeyeva, K Arasteh, et al.

Haemophilia : the Official Journal of the World Federation of Hemophilia|September 27, 2003

Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infectionD M DiMichele, G Mirani, P Wilfredo Canchis, et al.

Alimentary Pharmacology & Therapeutics|January 8, 2013

Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patientsA H Talal, J LaFleur, R Hoop, et al.

Pageof 2